Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
medicine management - search results
If you're not happy with the results, please do another search
Supporting and funding research in France
The French National Research Agency (ANR) is a public body which comes under the authority of the Ministry of Research, as this profile of the organisation by Open Access Government discovers
The detection, identification and monitoring of infectious diseases in Africa
The Southern African Centre for Infectious Disease Surveillance detail the issues around the detection, identification and monitoring of infectious diseases in Africa today
Prevention, early detection and effective therapy in melanoma
Dr Bettina Ryll from the Melanoma Patient Network Europe gives a patient advocacy perspective
Addressing the shortage of diabetes specialist nurses
Over three and a half million people in the UK are currently living with diabetes, and as that number continues to increase, the role of the diabetes specialist nurse (DSN) is becoming increasingly important. Swansea University Medical School responds to this training gap
The challenge facing patients with ‘Diabesity’
Chester Medical school shed light on the link between obesity and diabetes, the challenge facing patients with ‘Diabesity’ and the research contribution of the school in solving this problem
Diabetes: A paradigm case for rewarding innovation in value-based healthcare
Prof Dr Freimut Schliess, Director of Science & Innovation at Profil Institut für Stoffwechselforschung GmbH explains the important role of innovation when it comes to healthy living and active ageing, including his thoughts on the diabetes paradigm
Type 2 diabetes in the UK: Priorities for improving patient care
Professor John Wilding from the University of Liverpool charts priorities for improving patient care in the UK when it comes to the prevalent condition, Type 2 diabetes
Health, prevention and long-term care in Germany
The background of Jens Spahn, Germany’s Federal Minister of Health is examined here, plus the wider work of the Federal Ministry of Health concerning health, prevention and long-term care.
Blockchain: healthcare’s next frontier, or so much hype?
DataArt's Denis Baranov discusses how blockchain is likely to have a significant impact on the future of healthcare
Diabetes: A Global Health Challenge
Professor Nam H. Cho, President of the International Diabetes Federation (IDF) shares his expert views on the rise of diabetes across the globe
Muscular dystrophy: Present concerns and foreseen opportunities
Cecilia Van Cauwenberghe from the TechVision Group at Frost & Sullivan provides a detailed analysis of the present concerns and foreseen opportunities around muscular dystrophy (MD)
How Bayesian Networks are pioneering the ‘smart data’ revolution
Norman Fenton and Martin Neil ask what next after ‘big data’, focussing on how Bayesian Networks are pioneering the ‘smart data’ revolution
Sources of funding in the development of therapies for Huntington’s disease
Leora Fox, Jennifer Simpson and George Yohrling from the Huntington’s Disease Society of America explore the sources of funding in the development of therapies for Huntington’s disease (HD).
Diabetes & peripheral arterial disease
A change of paradigm improves patients’ outcomes with diabetes & peripheral arterial disease, according to the Division of Angiology at the Medical University of Vienna
The illusion of cancer and death: Illusion of the self
Sumith A Kularatne, PhD, discusses his thoughts on the illusion of cancer and death
Antimicrobial resistance (AMR): Why Europe still needs to talk about a preventable crisis
Michele Calabro’, European Health Management Association Policy and Communications Manager explains antimicrobial resistance (AMR), focussing on why Europe still needs to talk about a preventable crisis that could cause more deaths than cancer
The potential long-term environmental health consequences of urban wildfire debris
Birgit Puschner and Pamela Lein from the University of California, Davis share their expert views on the impacts of urban wildfire on chemical contamination in small backyard agriculture.
Treatment of Clostridium difficile associated diseases: One not so small step more… but still,...
Prof Colin J Suckling from the University of Strathclyde provides his seasoned opinion on a front-runner antibiotic for the treatment of Clostridium difficile associated diseases.
Evaluating multiple treatments within one study: Some practical considerations
Prof Thomas Jaki, Professor of Statistics at Lancaster University’s Medical and Pharmaceutical Statistics Research Unit tells us about some practical considerations around evaluating multiple treatments for patients.
Acute respiratory distress syndrome – diagnostics and therapeutics
Cecilia Van Cauwenberghe, from TechVision Group, Frost & Sullivan provides a detailed analysis of acute respiratory distress syndrome, focussing on the evolving diagnostics and therapeutics in the precision era of medicine.
